Know Labs has put forward additional proof-of-concept data from its needle-free blood sugar monitor, designed to continuously scan the blood through a person’s skin. The company said its digital, ...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW) today announced results from a new study titled, “Novel data preprocessing techniques in an expanded dataset improve machine learning ...

Please provide your email address to receive an email when new articles are posted on . A noninvasive sensor may measure glucose values by using dielectric spectroscopy to scan radiofrequencies.

Glucotrack (NASDAQ:GCTK) on Tuesday reported the successful completion of its first in human clinical study, sending shares ...

Glucotrack, Inc. has announced the successful completion of its first human clinical study for a continuous blood glucose monitor (CBGM), which is uniquely placed in the subclavian vein for real-time ...

Share on Pinterest The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring ...

FOR IMMEDIATE RELEASEGlucoModicum unveils Sofio™, the world’s first needle-free glucose monitor based on magneto-hydrodynamics ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Glooko, Inc., a leading provider of remote patient monitoring and digital health solutions for diabetes, today announced that it has acquired Monarch Medical ...

An elevated blood glucose level one hour after the oral glucose tolerance test (OGTT) signals a critical metabolic state—even before prediabetes. Affected individuals respond particularly well to ...

This article is the third in Microbiologics’ series on Optimal QC in the Clinical Laboratory. Previously, in this series we highlighted the importance of external and third-party quality control ...